Net clinical benefit of warfarin in individuals with atrial fibrillation across stroke risk and across primary and secondary care
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Net clinical benefit of warfarin in individuals with atrial fibrillation across stroke risk and across primary and secondary care
Authors
Keywords
-
Journal
HEART
Volume 103, Issue 3, Pages 210-218
Publisher
BMJ
Online
2016-09-01
DOI
10.1136/heartjnl-2016-309910
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Ischemic Stroke Risk in Patients With Atrial Fibrillation and CHA2DS2-VASc Score of 1
- (2016) Raed A. Joundi et al. STROKE
- Data Resource Profile: Clinical Practice Research Datalink (CPRD)
- (2015) Emily Herrett et al. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
- Should Atrial Fibrillation Patients With 1 Additional Risk Factor of the CHA2DS2-VASc Score (Beyond Sex) Receive Oral Anticoagulation?
- (2015) Tze-Fan Chao et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Type 2 diabetes and incidence of cardiovascular diseases: a cohort study in 1·9 million people
- (2015) Anoop Dinesh Shah et al. Lancet Diabetes & Endocrinology
- What is ‘valvular’ atrial fibrillation? A reappraisal
- (2014) Raffaele De Caterina et al. EUROPEAN HEART JOURNAL
- Heterogeneous associations between smoking and a wide range of initial presentations of cardiovascular disease in 1 937 360 people in England: lifetime risks and implications for risk prediction
- (2014) Mar Pujades-Rodriguez et al. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
- 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
- (2014) Craig T. January et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Blood pressure and incidence of twelve cardiovascular diseases: lifetime risks, healthy life-years lost, and age-specific associations in 1·25 million people
- (2014) Eleni Rapsomaniki et al. LANCET
- Socioeconomic Deprivation and the Incidence of 12 Cardiovascular Diseases in 1.9 Million Women and Men: Implications for Risk Prediction and Prevention
- (2014) Mar Pujades-Rodriguez et al. PLoS One
- Defining Disease Phenotypes Using National Linked Electronic Health Records: A Case Study of Atrial Fibrillation
- (2014) Katherine I. Morley et al. PLoS One
- Population-based cohort study of warfarin-treated patients with atrial fibrillation: incidence of cardiovascular and bleeding outcomes
- (2014) Arlene M Gallagher et al. BMJ Open
- The Net Clinical Benefit of Warfarin Anticoagulation in Atrial Fibrillation
- (2013) Daniel E. Singer ANNALS OF INTERNAL MEDICINE
- Risk scoring and thromboprophylactic treatment of patients with atrial fibrillation with and without access to primary healthcare data: Experience from the Stockholm health care system
- (2013) Tomas Forslund et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- Completeness and usability of ethnicity data in UK-based primary care and hospital databases
- (2013) Rohini Mathur et al. JOURNAL OF PUBLIC HEALTH
- Edoxaban versus Warfarin in Patients with Atrial Fibrillation
- (2013) Robert P. Giugliano et al. NEW ENGLAND JOURNAL OF MEDICINE
- Completeness and diagnostic validity of recording acute myocardial infarction events in primary care, hospital care, disease registry, and national mortality records: cohort study
- (2013) E. Herrett et al. BMJ-British Medical Journal
- Net Clinical Benefit of Warfarin in Patients With Atrial Fibrillation
- (2012) Leif Friberg et al. CIRCULATION
- Heart Disease and Stroke Statistics—2013 Update
- (2012) Alan S. Go et al. CIRCULATION
- 2012 focused update of the ESC Guidelines for the management of atrial fibrillation
- (2012) et al. EUROPEAN HEART JOURNAL
- Data Resource Profile: Cardiovascular disease research using linked bespoke studies and electronic health records (CALIBER)
- (2012) S. C. Denaxas et al. INTERNATIONAL JOURNAL OF EPIDEMIOLOGY
- The value of the CHA2DS2-VASc score for refining stroke risk stratification in patients with atrial fibrillation with a CHADS2 score 0–1: A nationwide cohort study
- (2012) Christian Torp-Pedersen et al. THROMBOSIS AND HAEMOSTASIS
- Representativeness of the dabigatran, apixaban and rivaroxaban clinical trial populations to real-world atrial fibrillation patients in the United Kingdom: a cross-sectional analysis using the General Practice Research Database
- (2012) Sally Lee et al. BMJ Open
- Apixaban versus Warfarin in Patients with Atrial Fibrillation
- (2011) Christopher B. Granger et al. NEW ENGLAND JOURNAL OF MEDICINE
- Rivaroxaban versus Warfarin in Nonvalvular Atrial Fibrillation
- (2011) Manesh R. Patel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Risks of thromboembolism and bleeding with thromboprophylaxis in patients with atrial fibrillation: A net clinical benefit analysis using a ‘real world’ nationwide cohort study
- (2011) Gregory Lip et al. THROMBOSIS AND HAEMOSTASIS
- The Myocardial Ischaemia National Audit Project (MINAP)
- (2010) E. Herrett et al. HEART
- Refining Clinical Risk Stratification for Predicting Stroke and Thromboembolism in Atrial Fibrillation Using a Novel Risk Factor-Based Approach
- (2009) Gregory Y.H. Lip et al. CHEST
- Dabigatran versus Warfarin in Patients with Atrial Fibrillation
- (2009) Stuart J. Connolly et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started